Hubert C. Chen - Jun 7, 2022 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Stock symbol
FBRX
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/8/2022, 04:24 PM
Previous filing
May 20, 2021
Next filing
Feb 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBRX Stock Option (right to buy) Award $0 +250K $0.00 250K Jun 7, 2022 Common Stock 250K $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Inducement Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 7, 2022.

Remarks:

President and Chief Scientific Officer